These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 20492852)

  • 1. A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up.
    van Apeldoorn FJ; Timmerman ME; Mersch PP; van Hout WJ; Visser S; van Dyck R; den Boer JA
    J Clin Psychiatry; 2010 May; 71(5):574-86. PubMed ID: 20492852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined.
    Van Apeldoorn FJ; Van Hout WJ; Timmerman ME; Mersch PP; den Boer JA
    J Affect Disord; 2013 Sep; 150(2):313-9. PubMed ID: 23676529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SECOND-STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA-CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL.
    Payne LA; White KS; Gallagher MW; Woods SW; Shear MK; Gorman JM; Farchione TJ; Barlow DH
    Depress Anxiety; 2016 May; 33(5):392-9. PubMed ID: 26663632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia.
    van Apeldoorn FJ; van Hout WJ; Mersch PP; Huisman M; Slaap BR; Hale WW; Visser S; van Dyck R; den Boer JA
    Acta Psychiatr Scand; 2008 Apr; 117(4):260-70. PubMed ID: 18307586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facing the fear--clinical and neural effects of cognitive behavioural and pharmacotherapy in panic disorder with agoraphobia.
    Liebscher C; Wittmann A; Gechter J; Schlagenhauf F; Lueken U; Plag J; Straube B; Pfleiderer B; Fehm L; Gerlach AL; Kircher T; Fydrich T; Deckert J; Wittchen HU; Heinz A; Arolt V; Ströhle A
    Eur Neuropsychopharmacol; 2016 Mar; 26(3):431-44. PubMed ID: 26837851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of CBT, SSRI, and CBT+SSRI in the treatment for panic disorder.
    van Apeldoorn FJ; Stant AD; van Hout WJ; Mersch PP; den Boer JA
    Acta Psychiatr Scand; 2014 Apr; 129(4):286-95. PubMed ID: 23834587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive-behavior therapy for discontinuation of SSRI treatment of panic disorder: a case series.
    Whittal ML; Otto MW; Hong JJ
    Behav Res Ther; 2001 Aug; 39(8):939-45. PubMed ID: 11480834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of personality disorder on the treatment of panic disorder--comparison study.
    Prasko J; Houbová P; Novák T; Záleský R; Espa-Cervená K; Pasková B; Vyskocilová J
    Neuro Endocrinol Lett; 2005 Dec; 26(6):667-74. PubMed ID: 16380683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of panic disorder with agoraphobia in an anxiety disorders clinic: factors influencing psychiatrists' treatment choices.
    Starcevic V; Linden M; Uhlenhuth EH; Kolar D; Latas M
    Psychiatry Res; 2004 Jan; 125(1):41-52. PubMed ID: 14967551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
    Simon NM; Otto MW; Worthington JJ; Hoge EA; Thompson EH; Lebeau RT; Moshier SJ; Zalta AK; Pollack MH
    J Clin Psychiatry; 2009 Nov; 70(11):1563-70. PubMed ID: 19814948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open study of the effectiveness of Internet treatment for panic disorder delivered in a psychiatric setting.
    Bergström J; Andersson G; Karlsson A; Andréewitch S; Rück C; Carlbring P; Lindefors N
    Nord J Psychiatry; 2009; 63(1):44-50. PubMed ID: 18985514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, controlled trial of the effectiveness of cognitive-behavioral therapy and sertraline versus a waitlist control group for anxiety disorders in older adults.
    Schuurmans J; Comijs H; Emmelkamp PM; Gundy CM; Weijnen I; van den Hout M; van Dyck R
    Am J Geriatr Psychiatry; 2006 Mar; 14(3):255-63. PubMed ID: 16505130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does maintenance CBT contribute to long-term treatment response of panic disorder with or without agoraphobia? A randomized controlled clinical trial.
    White KS; Payne LA; Gorman JM; Shear MK; Woods SW; Saksa JR; Barlow DH
    J Consult Clin Psychol; 2013 Feb; 81(1):47-57. PubMed ID: 23127290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective serotonin reuptake inhibitors in the treatment of panic disorder and agoraphobia.
    Bakker A; van Balkom AJ; van Dyck R
    Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S25-30. PubMed ID: 11110016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined antidepressants and CBT for panic disorder with agoraphobia.
    Coupland NJ
    J Psychiatry Neurosci; 2008 Mar; 33(2):176. PubMed ID: 18330461
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone.
    Kampman M; Keijsers GP; Hoogduin CA; Hendriks GJ
    J Clin Psychiatry; 2002 Sep; 63(9):772-7. PubMed ID: 12363116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled study of paroxetine and cognitive-behavioural therapy for late-life panic disorder.
    Hendriks GJ; Keijsers GP; Kampman M; Oude Voshaar RC; Verbraak MJ; Broekman TG; Hoogduin CA
    Acta Psychiatr Scand; 2010 Jul; 122(1):11-9. PubMed ID: 19958308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of gradual discontinuation of selective serotonin reuptake inhibitors in panic disorder with agoraphobia.
    Fava GA; Bernardi M; Tomba E; Rafanelli C
    Int J Neuropsychopharmacol; 2007 Dec; 10(6):835-8. PubMed ID: 17224089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of the cost and the effectiveness of a psychotherapy for panic disorder with agoraphobia (PDA) versus a treatment combining pharmacotherapy and psychotherapy].
    Marchand A; Germain V; Reinharz D; Mainguy N; Landry P
    Sante Ment Que; 2004; 29(2):201-20. PubMed ID: 15928793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global measures of outcome in a controlled comparison of pharmacological and psychological treatment of panic disorder and agoraphobia in primary care.
    Sharp DM; Power KG; Simpson RJ; Swanson V; Anstee JA
    Br J Gen Pract; 1997 Mar; 47(416):150-5. PubMed ID: 9167318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.